Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stress bleeding. 2. Prophylaxis]

M Tryba1

  • 1Universitätsklinik für Anästhesiologie, Intensiv- und Schmerztherapie, "Bergmannsheil" Bochum.

Der Anaesthesist
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Optimizing emergency and ICU care is key for stress ulcer prophylaxis. While drugs like sucralfate show promise in reducing mortality, gastric alkalinization from prophylaxis can increase pneumonia risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S2e guideline: positioning and early mobilisation in prophylaxis or therapy of pulmonary disorders : Revision 2015: S2e guideline of the German Society of Anaesthesiology and Intensive Care Medicine (DGAI).

Der Anaesthesist·2015
Same author

[Short version S2e guidelines: "Positioning therapy and early mobilization for prophylaxis or therapy of pulmonary function disorders"].

Der Anaesthesist·2015
Same author

[Euthanasia and physician-assisted suicide : Attitudes of physicians and nurses].

Schmerz (Berlin, Germany)·2015
Same author

[Treatment gaps in acute pain therapy?: only a question of interpretation].

Der Anaesthesist·2013
Same author

Meta-analysis of dropout rates in randomized controlled clinical trials: opioid analgesia for osteoarthritis pain.

Schmerz (Berlin, Germany)·2011
Same author

[An algorithm for postoperative pain management in visceral and thoracic surgery: an observational study].

Zentralblatt fur Chirurgie·2011
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Area of Science:

  • Gastroenterology and Critical Care Medicine
  • Pharmacology of Stress Ulcer Prophylaxis

Context:

  • Stress ulcers are a significant concern in critically ill patients.
  • Current preventive strategies focus on reducing gastric acidity, enhancing mucosal defenses, and improving microcirculation.

Purpose:

  • To review the efficacy and adverse effects of various stress ulcer prophylaxis (SUP) agents.
  • To highlight the importance of optimized critical care regimens for SUP.

Summary:

  • H2-antagonists and antacids reduce gastric acidity; sucralfate and pirenzepine strengthen mucosal defenses and improve microcirculation.
  • Pirenzepine demonstrated superiority over H2-antagonists in neurosurgical patients.
  • Prostaglandins and omeprazole lack sufficient data for SUP.
  • Gastric alkalinization from SUP can lead to nosocomial pneumonia, particularly in ventilated patients.

Related Experiment Videos

  • Sucralfate may reduce mortality, potentially via inhibition of bacterial translocation, unlike antacids or H2-antagonists.

    • Impact:

    • Identifies key strategies for effective stress ulcer prophylaxis in intensive care units.
    • Warns of the risk of nosocomial pneumonia associated with certain SUP methods.
    • Suggests sucralfate as a potentially mortality-reducing agent in specific patient populations.